| 2020-09-08 | Class updated from VUS4 to disease-causing; subclass is not defined yet |
Variant NM_000492.4:c.3294G>C
| Name | NM_000492.4:c.3294G>C |
| Protein name | NP_000483.3:p.(Trp1098Cys) |
| Genomic name (hg19) | chr7:g.117251789G>C UCSC |
| Genomic name (hg38) | chr7:g.117611735G>C UCSC |
| #Exon/intron | exon 20 |
| Legacy Name | W1098C |
| Class | disease-causing |
| WT sequence | TCTTGTACCTGTCAACACTGCGCTG G TTCCAAATGAGAATAGAAATGATTT |
| Mutant sequence | TCTTGTACCTGTCAACACTGCGCTG C TTCCAAATGAGAATAGAAATGATTT |
![]() Not found |
![]() | dbSNP rs397508533 |
![]() | ![]() |
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| IVA | no | no | no | no |
| TEZ-IVA | no | no | no | no |
| ELX-TEZ-IVA | yes | no | yes | no |
| VNZ-TEZ-DIVA | yes | no | no | yes |
clinical and functional data presented above are provided by Vertex
1 individuals carrying this variant are reported in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 3 |
|---|---|
| Asymptomatic compound heterozygote | 1 |
| CFTR-RD | 1
|
| Pending non-CF | 1 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| Pending non-CF | 753 | heterozygote | CF-causing - Trans |
| Other | 5243 | heterozygote | |
| Asymptomatic compound heterozygote | 6486 | heterozygote | CFTR-RD-causing - Trans |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|